Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 13, 2022
Patent Application Number
16863770
Date Filed
April 30, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
The present application provides tricyclic amine compounds, which are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
